← The Wire
RIGLNasdaq
RIGEL PHARMACEUTICALS INC
Pharmaceutical Preparations · DE · CIK 1034842
Develops and provides novel therapies for hematologic disorders and cancer by targeting critical disease signaling pathways
red 8-K · 90d
$608M
Market cap
$39.04
Last close
+0.9%
1D
+9.3%
5D
284K
Volume
Price · last 39 sessions+32.2%
May 4L $26.04 · H $39.04Jun 29
355
Total filings
Jun 17, 2026
Last filing
12/31
Fiscal year end
8-KAcquisition / DispositionJun 17, 20268-KExecutive Change · Shareholder VoteMay 20, 20268-KMaterial AgreementMay 12, 20268-KResults of OperationsMay 5, 202610-Q10-QMay 5, 20268-KAgreement TerminatedApr 21, 2026DEFA14ADEFA14AApr 3, 2026DEF 14ADEF 14AApr 3, 20268-KResults of OperationsMar 3, 202610-K10-KMar 3, 20268-KExecutive ChangeFeb 3, 20268-KResults of Operations · Company UpdateJan 12, 20268-KCompany UpdateDec 10, 20258-KResults of OperationsNov 4, 202510-Q10-QNov 4, 202510-Q10-QAug 5, 20258-KResults of OperationsAug 5, 20258-KExecutive Change · Shareholder VoteMay 23, 20258-KResults of OperationsMay 6, 202510-Q10-QMay 6, 2025DEFA14ADEFA14AApr 10, 2025DEF 14ADEF 14AApr 10, 20258-KCompany UpdateMar 27, 20258-KExecutive ChangeMar 10, 20258-KResults of OperationsMar 4, 202510-K10-KMar 4, 20258-KResults of Operations · Company UpdateJan 13, 20258-KCompany UpdateDec 9, 20248-KResults of OperationsNov 7, 202410-Q10-QNov 7, 20248-KExecutive ChangeSep 19, 20248-KMaterial AgreementSep 3, 20248-KResults of OperationsAug 6, 202410-Q10-QAug 6, 20248-KSecurity-Holder Rights · Bylaw AmendmentJun 27, 20248-KCompany UpdateJun 25, 20248-KExecutive Change · Shareholder VoteMay 29, 20248-KResults of OperationsMay 7, 202410-Q10-QMay 7, 20248-KMaterial AgreementApr 12, 2024DEFA14AFORM DEFA14AApr 10, 2024DEF 14ADEF 14AApr 10, 20248-KResults of OperationsMar 5, 202410-K10-KMar 5, 20248-KMaterial Agreement · Acquisition / DispositionFeb 22, 2024SC 13GMS INITIALFeb 9, 20248-KResults of Operations · Company UpdateJan 8, 20248-KDelisting NoticeNov 30, 20238-KResults of OperationsNov 7, 202310-Q10-QNov 7, 20238-KResults of OperationsAug 1, 202310-Q10-QAug 1, 20238-KExecutive Change · Shareholder VoteMay 30, 20238-KResults of OperationsMay 2, 202310-Q10-QMay 2, 2023DEFA14AFORM DEFA14AApr 14, 2023DEF 14ADEF 14AApr 14, 20238-KResults of OperationsMar 7, 202310-K10-KMar 7, 2023SC 13GSC 13GFeb 22, 2023SC 13GSC 13GFeb 14, 2023SC 13GSC 13GFeb 14, 2023SC 13GSC 13GFeb 6, 20238-KExecutive ChangeFeb 3, 20238-KResults of Operations · Company UpdateJan 9, 20238-KCompany UpdateDec 2, 20228-KDelisting NoticeNov 29, 202210-Q10-QNov 3, 20228-KMaterial Agreement · Results of OperationsNov 3, 20228-KCompany UpdateNov 1, 20228-KExecutive Change · Exit / Disposal CostsOct 11, 2022SC 13GSC 13GSep 22, 20228-KMaterial Agreement · Results of OperationsAug 2, 202210-Q10-QAug 2, 20228-KCompany UpdateJul 25, 20228-KCompany UpdateJun 23, 20228-KCompany UpdateJun 8, 20228-KExecutive Change · Shareholder VoteMay 23, 20228-KResults of OperationsMay 3, 202210-Q10-QMay 3, 2022
Insider Activity
In the 90 days to Feb 20, 2026: 1 sold $145K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 20, 2026 | Moos Walter HDirector | Sell | 4,000 | $36.36 | $145K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance